绝经后骨质疏松症:绝经期激素治疗和选择性雌激素受体调节剂
Jyotsna Rani1, Swati Swati2, Meeta Meeta3
1IGIMS, Patna, Bihar India.
Indian journal of orthopaedics
|December 18, 2023
概括
激素治疗 (HT) 是有效的预防骨折和骨损失在绝经后的妇女,特别是那些经历过早期绝经. 它仍然是骨健康管理的可行选择,即使在绝经后的10年内,也需要仔细考虑.
科学领域:
- 内分泌学 在内分泌学.
- 老年病的医生 老年病的医生
- 妇女健康 妇女健康
背景情况:
- 骨质疏松症是一种沉默的疾病,具有重大社会经济影响.
- 专业人士和消费者之间存在关于骨质疏松症诊断和管理的知识差距.
- 绝经后的激素治疗 (HT) 适用于缓解症状,泌尿器缩和骨健康.
研究的目的:
- 审查关于骨质疏松症管理的绝经后激素治疗的证据.
- 专注于单独或组合使用HT治疗绝经后骨质疏松症.
- 解决骨质疏松症管理方面的知识差距.
主要方法:
- 在PubMed和国家医学图书馆的文献评论.
- 对作者临床经验的分析.
- 专注于在更年期的不同阶段和骨健康中对HT的证据.
主要成果:
- 对于患骨质疏松症风险较高的早期绝经后妇女来说,HT是具有成本效益的.
- HT可以在不同人群中预防骨质疏松性骨折,包括低风险个体.
- 所有的HT制剂都对骨健康有效,其效果在治疗期间持续.
结论:
- 高血压是一种主要疗法,用于预防早更年期和二次无血流的骨质损失.
- 延长HT使用是绝经后10年以后,骨质减少的女性的选择,需要风险-益处咨询.
- 基本的处方前工作和年度后续对HT至关重要.
相关概念视频
Menopause
170
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
170
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Hormonal Regulation of the Menstrual Cycle
400
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
400
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
170
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
170


